Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1977 3
1980 3
1981 3
1982 1
1983 1
1984 1
1985 2
1986 3
1987 2
1988 4
1989 5
1990 3
1991 5
1992 4
1993 5
1994 7
1995 13
1996 4
1997 19
1998 7
1999 17
2000 14
2001 22
2002 15
2003 30
2004 16
2005 20
2006 20
2007 21
2008 22
2009 25
2010 34
2011 32
2012 21
2013 31
2014 26
2015 29
2016 35
2017 38
2018 29
2019 27
2020 33
2021 28
2022 23
2023 23
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

670 results

Results by year

Filters applied: . Clear all
Page 1
Breast Cancer Epidemiology, Prevention, and Screening.
Winters S, Martin C, Murphy D, Shokar NK. Winters S, et al. Prog Mol Biol Transl Sci. 2017;151:1-32. doi: 10.1016/bs.pmbts.2017.07.002. Epub 2017 Oct 10. Prog Mol Biol Transl Sci. 2017. PMID: 29096890 Review.
Globally, breast cancer is both the most commonly occurring cancer and the commonest cause of cancer death among women. Available data suggest that incidence and mortality in high-resource countries has been declining whereas incidence and mortality in …
Globally, breast cancer is both the most commonly occurring cancer and the commonest cause of cancer death among …
Management of High-Risk Breast Lesions.
Bahl M. Bahl M. Radiol Clin North Am. 2021 Jan;59(1):29-40. doi: 10.1016/j.rcl.2020.08.005. Radiol Clin North Am. 2021. PMID: 33222998 Review.
High-risk breast lesions (HRLs) are a group of heterogeneous lesions that can be associated with a synchronous or adjacent breast cancer and that confer an elevated lifetime risk of breast cancer. ...In addition, imaging surveillan …
High-risk breast lesions (HRLs) are a group of heterogeneous lesions that can be associated with a synchronous or adjacent …
Screening for breast cancer with mammography.
Gøtzsche PC, Jørgensen KJ. Gøtzsche PC, et al. Cochrane Database Syst Rev. 2013 Jun 4;2013(6):CD001877. doi: 10.1002/14651858.CD001877.pub5. Cochrane Database Syst Rev. 2013. PMID: 23737396 Free PMC article. Review.
OBJECTIVES: To assess the effect of screening for breast cancer with mammography on mortality and morbidity. ...Three trials with adequate randomisation did not show a statistically significant reduction in breast cancer mortality …
OBJECTIVES: To assess the effect of screening for breast cancer with mammography on mortality and morbidity. ... …
Screening in patients with increased risk of breast cancer (part 1): pros and cons of MRI screening.
Alonso Roca S, Delgado Laguna AB, Arantzeta Lexarreta J, Cajal Campo B, Santamaría Jareño S. Alonso Roca S, et al. Radiologia (Engl Ed). 2020 Jul-Aug;62(4):252-265. doi: 10.1016/j.rx.2020.01.007. Epub 2020 Mar 30. Radiologia (Engl Ed). 2020. PMID: 32241593 Free article. Review. English, Spanish.
Screening plays an important role in women with a high risk of breast cancer. ...Nevertheless, the current guidelines do not totally agree about the recommendations for MRI screening in some subgroups of patients. The first part of this article
Screening plays an important role in women with a high risk of breast cancer. ...Nevertheless, the current guide
Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD. Myers ER, et al. JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183. JAMA. 2015. PMID: 26501537 Review.
Included studies (7 reviews, 10 RCTs, 72 observational, 1 modeling) provided evidence on the association between screening with mammography, CBE, or both and prespecified critical outcomes among women at average risk of breast cancer (no known g …
Included studies (7 reviews, 10 RCTs, 72 observational, 1 modeling) provided evidence on the association between screening with ma
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Nelson HD, Fu R, Cantor A, Pappas M, Daeges M, Humphrey L. Nelson HD, et al. Ann Intern Med. 2016 Feb 16;164(4):244-55. doi: 10.7326/M15-0969. Epub 2016 Jan 12. Ann Intern Med. 2016. PMID: 26756588 Free article. Review.
PURPOSE: To review studies of the effectiveness of breast cancer screening in average-risk women. DATA SOURCES: MEDLINE and Cochrane databases to 4 June 2015. ...Risk reduction was 25% to 31% for women aged 50 to 69 years in observational …
PURPOSE: To review studies of the effectiveness of breast cancer screening in average-risk women. DATA SOURCES: …
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, de Koning HJ, Miglioretti DL, van Ravesteyn NT, Schechter C, Sprague BL, Tosteson ANA, Trentham-Dietz A, Weaver D, Yaffe MJ, Yeh JM, Couch FJ, Hu C, Kraft P, Polley EC, Mandelblatt JS, Kurian AW, Robson ME; Breast Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET), in collaboration with the Breast Cancer Surveillance Consortium (BCSC), and the Cancer Risk Estimates Related to Susceptibility (CARRIERS) Consortium. Lowry KP, et al. JAMA Oncol. 2022 Apr 1;8(4):587-596. doi: 10.1001/jamaoncol.2021.6204. JAMA Oncol. 2022. PMID: 35175286 Free PMC article.
MAIN OUTCOMES AND MEASURES: Estimated lifetime breast cancer mortality reduction, life-years gained, breast cancer deaths averted, total screening examinations, false-positive screenings, and benign biopsies per 1000 women scree
MAIN OUTCOMES AND MEASURES: Estimated lifetime breast cancer mortality reduction, life-years gained, breast c
Artificial intelligence for breast cancer detection in screening mammography in Sweden: a prospective, population-based, paired-reader, non-inferiority study.
Dembrower K, Crippa A, Colón E, Eklund M, Strand F; ScreenTrustCAD Trial Consortium. Dembrower K, et al. Lancet Digit Health. 2023 Oct;5(10):e703-e711. doi: 10.1016/S2589-7500(23)00153-X. Epub 2023 Sep 8. Lancet Digit Health. 2023. PMID: 37690911 Free article. Clinical Trial.
The primary outcome was screen-detected breast cancer within 3 months of mammography, and the primary analysis was to assess non-inferiority (non-inferiority margin of 0.15 relative reduction in breast cancer diagnoses) of double r …
The primary outcome was screen-detected breast cancer within 3 months of mammography, and the primary analysis w …
Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI).
Mann RM, Athanasiou A, Baltzer PAT, Camps-Herrero J, Clauser P, Fallenberg EM, Forrai G, Fuchsjäger MH, Helbich TH, Killburn-Toppin F, Lesaru M, Panizza P, Pediconi F, Pijnappel RM, Pinker K, Sardanelli F, Sella T, Thomassin-Naggara I, Zackrisson S, Gilbert FJ, Kuhl CK; European Society of Breast Imaging (EUSOBI). Mann RM, et al. Eur Radiol. 2022 Jun;32(6):4036-4045. doi: 10.1007/s00330-022-08617-6. Epub 2022 Mar 8. Eur Radiol. 2022. PMID: 35258677 Free PMC article.
Breast density is an independent risk factor for the development of breast cancer and also decreases the sensitivity of mammography for screening. Consequently, women with extremely dense breasts face an increased risk of late d
Breast density is an independent risk factor for the development of breast cancer and also decreases the sensiti
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
Oeffinger KC, Fontham ET, Etzioni R, Herzig A, Michaelson JS, Shih YC, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AM, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, Wender R; American Cancer Society. Oeffinger KC, et al. JAMA. 2015 Oct 20;314(15):1599-614. doi: 10.1001/jama.2015.12783. JAMA. 2015. PMID: 26501536 Free PMC article.
Early detection has been shown to be associated with reduced breast cancer morbidity and mortality. OBJECTIVE: To update the American Cancer Society (ACS) 2003 breast cancer screening guideline for women at average risk
Early detection has been shown to be associated with reduced breast cancer morbidity and mortality. OBJECTIVE: T
670 results